The Center for Medicare & Medicaid Innovation has launched the Enhancing Oncology Model (EOM) to enhance the quality of care provided to cancer patients covered under Medicare Traditional while reducing Medicare fee-for-service expenditures, with nonbinding applications for the new program due by September 30, 2022. In this week’s Sg2 Perspectives, we’re joined by Sg2 Associate Principal Keely Macmillan who discusses the differences between EOM and the previous Oncology Care Model, why health care organizations should consider participating, and how EOM can assist with organizational health equity initiatives.

Learn more about the Enhancing Oncology Model in Sg2’s blog post and educational web series.

We are always excited to get ideas and feedback from our listeners. You can reach us at [email protected], find us on Twitter as @Sg2HealthCare, or visit the Sg2 company page on LinkedIn.